Background Trimethylamine N‐oxide (TMAO) contributes to cardiovascular disease through
its prothrombotic, proatherothrombotic, and proinflammatory effects. We aimed to evaluate …

Background: Trimethylamine N-oxide (TMAO) has been recognized as a risk factor for
cardiovascular disease. However, the role of TMAO in ischemic stroke remains unclear. As …

Background and Purpose—Trimethylamine N-oxide (TMAO)—a gut derived metabolite—
has been shown to be atherogenic. It remains unknown whether TMAO is associated with …

Background The association of circulating trimethylamine‐N‐oxide (TMAO) with stroke has
received limited attention. To address this gap, we examined the associations of serial …

Background Although trimethylamine-N-oxide (TMAO) shows a notable correlation with
cardiovascular disease, its association with acute ischemic stroke (AIS) remains uncertain …

Introduction: Trimethylamine-N-oxide (TMAO) is correlated with atherosclerosis and vascular
diseases such as coronary heart disease and ischemic stroke. The aim of the study was to …

Abstract Background Trimethylamine N‐oxide (TMAO) is a gut‐derived atherogenic
metabolite. However, the role of TMAO and its precursors in the development of stroke …

Objective To investigate whether elevated plasma trimethylamine N-oxide (TMAO) levels are
associated with initial stroke severity and infarct volume. Methods This cross-sectional study …

Background and aims: Trimethylamine N-oxide (TMAO), a pro-atherosclerotic intestinal
microbiota metabolite, has mechanistic links to atherosclerosis development and …

Objectives To explore the association of plasma trimethylamine N-oxide (TMAO)
concentration with large artery atherosclerotic (LAA) ischemic stroke and its role in …